Rhabdomyosarcoma: Clinical Trials

3 trials for Rhabdomyosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Terminated 1, Unknown 1

Follow Rhabdomyosarcoma: new trials by email Literature Review of Rhabdomyosarcoma trials Research Report on Rhabdomyosarcoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Indo-cyanine Green (ICG) in Paediatric Oncology MIS
Indocyanine green - Pediatric Renal Tumor, Metastatic Osteosarcoma
Phase 4CompletedBirmingham Women's and Children's NHS Foundation Trust202021-04-302023-08-14
Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
Taclonex Ointment and Hydrogel Patch, Taclonex Ointment - Plaque Psoriasis, Psoriasis Vulgaris
Phase 4TerminatedUniversity of California, San Francisco352009-06-012019-04-18
EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children
doxorubicin, cytoxan - Rhabdomyosarcoma
Phase 4UnknownSheba Medical Center2006-06-20

Narrower conditions

Neoplasms (1)  ·  Osteosarcoma (1)  ·  Psoriasis (1)  ·  Rhabdomyosarcoma, Alveolar (1)  ·  Sarcoma (1)  ·  Sarcoma, Ewing (1)

Broader conditions

Myosarcoma (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Neoplasms, Muscle Tissue (3)  ·  Neoplasms (2)  ·  Sarcoma (2)  ·  Neoplasms, Bone Tissue (1)  ·  Neoplasms, Connective Tissue (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Papulosquamous (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Cyclophosphamide (1)  ·  Doxorubicin (1)  ·  Indocyanine Green (1)

Sponsors

Birmingham Women's and Children's NHS Foundation Trust (1)  ·  Sheba Medical Center (1)  ·  University of California, San Francisco (1)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

Iris Kventsel, MD (1)  ·  John Koo, MD (1)  ·  Max Pachl (1)

Results publications

PMID 31562043, PMID 34606881, PMID 36848614, PMID 40053891